Robert L. Parry
Harvard University
8 Papers
163 Citations
Robert L. Parry is an academic researcher from Harvard University. The author has contributed to research in topics: In vivo & Epidermoid carcinoma. The author has an hindex of 5, co-authored 8 publications.
Chat about Author
Papers
•Journal Article
Human Müllerian Inhibiting Substance Inhibits Tumor Growth in Vitro and in Vivo
TL;DR: It is concluded that rhMIS inhibits the growth of certain tumor cell lines in vitro and in vivo.
71
•Journal Article
Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
TL;DR: The responsiveness of ocular melanoma to MIS broadens the spectrum of tumors that might be treated with MIS and suggests further investigation of other neural crest tumors.
38
Patent
Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression
Patricia K. Donahoe,Tai Wai Chin,Robert L. Parry,James Epstein,Richard C. Ragin,David T MacLaughlin,Edward M. Barksdale +6 more
- 18 Jun 1993
TL;DR: In this paper, a method for modulating class I histocompatibility antigens with MIS and EGF was proposed, where gene therapy treatments for inhibiting growth of certain tumors are also provided.
26
•Journal Article
Computer-aided cell colony counting.
TL;DR: This paper presents a computer software application that performs accurate, reproducible cell colony counts with a minimum of user generated bias based upon the Apple IICX computer system with Image software and AppleScan.
19
Application of tissue mesodissection to molecular cancer diagnostics
TL;DR: The mesodissection platform as performed by the MilliSect instrument for tissue dissection is cost-effective; it functions comparably to laser-based dissection and which can be adopted into a clinical diagnostic workflow.
5